According to EvaluateMedTech's statistics, the global medical device market will reach $477.5 billion in 2020, with a compound annual growth rate of 4.1% between 2016 and 2020. EvaluateMed Tech predicts that in vitro diagnostic products (IVD) will remain the most sub-sector in 2020. In 2020, IVD (in vitro diagnostic) sales were approximately $67.3 billion, accounting for 13% of global medical device sales, and a compound annual growth rate of 6.1% between 2015 and 2020, higher than the overall 5% of the medical device industry during the same period. The growth rate is based on publicly available data from 300 of the world's top medical device manufacturers. According to EvaluateMedTech's "2015-2020 Global Medical Device Market" report, by 2020, Medtronic will become a medical device brother, which will occupy 7% of the global medical device market, with annual sales of 34.9 billion US dollars. Johnson & Johnson has only $27.5 billion in sales. The report points out that the change in status is because Medtronic has been aggressively acquiring some of the smaller medical technology companies, and this year it has completed the largest acquisition in the history of the industry – Covidien for $49.9 billion. The company is included in the bag. Since the announcement of a deal with Covidien, Medtronic has implemented 11 other $1.6 billion acquisitions. The industry's leading leader, Johnson & Johnson (J&J), is doing the opposite: it is divesting the medical technology department to further highlight its focus. Although the ultimate goal of some of the medical device companies in the early stages of development is still to be acquired by large companies, maintaining independence and listing has become a trend in the market. In the first half of 2015, IPOs in the medical device sector raised a total of US$800 million, a 41% decrease from the US$1.4 billion in the same period in 2014. By 2020, the global medical device market will be close to 500 billion US dollars, and in vitro diagnostic products will remain the largest area. Summary of key points Global pharmaceutical sales in 2020 are expected to reach $477.5 billion; The global medical technology market is expected to grow more slowly than the prescription drug market, with a compound annual growth rate of 4.9% for prescription drugs between 2013 and 2020. In the first half of 2015, the value of total M&A transactions increased by 166% to 84 billion; in January 2015, Medtronic acquired US$44.9 billion for Covidien as the largest transaction in the history of medical devices; After the completion of Covidien's acquisition from 1st of 2015, Medtronic steals the top spot and expects the company to achieve sales of US$349 in 2020; Johnson & Johnson continues to maintain its leading position in the orthopedics market, with sales expected to reach $10.5 billion in 2020; In vitro diagnosis remains the highest sub-sector, with sales expected to reach $67.3 billion in 2020; Roche is expected to lead the IVD industry with $11.9 billion in sales by 2020; Global pharmaceutical R&D spending is expected to increase by 3.5% per year, and medical device sales are expected to reach $30.5 billion by 2020; Medtronic will occupy top 1 in 2020 R&D investment, and its expenditure is expected to reach US$2.5 billion; PMAs and HDE increased by 43% to 33; 510(k) increased by 5% to 3244; By the end of 2015 to the end of August, the FDA approved 30 new PMAs, a 50% increase over the same period in 2014; heart disease dominates; In the first quarter of 2015, venture financing fell by 14%, and the number of transactions fell by 13%; Medical technology IPO activity declined, but overall it still showed an upward trend. The scale of the global medical equipment market in 2020 The global medical device market is expected to grow at a compound annual growth rate of 4.1% from 2015 to 2020. In 2020, global medical device sales are expected to reach US$477.5 billion. In vitro diagnostic products (IVD) will remain the largest sub-sector in the market. By 2020, sales will reach US$67.3 billion, accounting for 14.1% of the global medical device market. In the same period, the IVD market will grow at a rate of 6.1% per year. The fastest growth will be in the neurology product market, which will grow at a compound annual growth rate of 6.9% and reach a market size of $9.5 billion by 2020. Global 2020 machinery sales top20 company Medtronic is expected to become the largest-selling medical device company by 2020 with sales of $34.9 billion and a 7% global market share. As Johnson & Johnson's clinical diagnostic company Ortho-Clinical Diagnostics will be acquired by private equity funds, its market share will fall from 7.8% in 2014 to 6.4% in 2020. Excluding those companies involved in major M&A activities, most companies are expected to shrink their valuations by 2020, due to the depreciation of the euro against the US dollar in 2015.
Plant extracts refer to substances extracted or processed from plants (all or a part of plants) using appropriate solvents or methods. They can be used in the pharmaceutical industry, food industry, health industry, beauty industry and other industries.
Plant extracts are based on plants as raw materials. According to the needs of the use of the final product extracted, through physical and chemical extraction and separation processes, one or more effective ingredients in the plant are obtained and concentrated without changing the effective ingredients. The product formed by the structure. According to the different components of the extracted plants, glycosides, acids, polyphenols, polysaccharides, terpenoids, flavonoids, alkaloids, etc. Are formed; according to different properties, they can be divided into vegetable oils, extracts, powders,crystalline powder, etc.
Natural Phytoextraction,Plant Extracted,Plant Extract Powder,Corn Silk Extract Amazy Organic Biotech Co.,Ltd , https://www.amazyorganic.com
